43 Interesting findings come from a meta-analysis conducted by Zhang et al who showed that compared with placebo or control drugs (empagliflozin, sitagliptin, liraglutide, and dulaglutide), oral dose of semaglutide significantly decreased HbA1c level
The primary role of Semaglutide is is to help patients shed weight
In 2023, the FDA approved tirzepatide for obesity, which, according to Gratzl and colleagues, contributed to an increase in prescribing trends of GLP-1 medications
A Phase 2 trial testing an HDT alongside standard TBM antibiotics could in principle move faster than if these drugs had to clear the full de novo safety pipeline first, as noted in a 2025 European Journal of Medical Research review of host-directed TB therapies
At Boston Childrens Adolescent Weight-Loss (Bariatric) Surgery Program, clinicians are using both bariatric surgery and GLP-1RAs along with behavioral and lifestyle approaches to help teens and young adults manage their obesity